Olin (OLN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Feb, 2026Executive summary
Fourth quarter 2025 results were significantly below expectations, with a net loss of $85.7 million and adjusted EBITDA of $67.7 million, due to operational issues, weak demand, higher costs, and restructuring across all segments.
Strategic actions included a long-term EDC supply agreement with Braskem, expansion of infrastructure in Brazil, and closure of the Guarujá, Brazil, epoxy plant for cost savings.
Epoxy segment achieved volume growth in Europe and secured significant growth contracts, while Winchester reduced inventory and right-sized costs in response to lower commercial ammunition demand.
Value-first commercial approach preserved ECU values and supported long-term agreements, including the Braskem deal to upgrade export EDC values.
Generated $321 million in operating cash flow in Q4, keeping net debt flat year-over-year.
Financial highlights
Full-year 2025 adjusted EBITDA was $651.8 million, down from $873.9 million in 2024; net loss for FY25 was $43.4 million.
Q4 2025 net loss per diluted share was $(0.75); sales for Q4 2025 were $1,665.1 million, nearly flat year-over-year.
Year-end 2025 liquidity stood at $1 billion, with a cash balance of $167.6 million.
Achieved $248 million in working capital reductions in 2025, excluding tax timing.
Capital spending totaled $226.3 million in 2025; $51 million of stock repurchased during the year.
Outlook and guidance
First quarter 2026 earnings and adjusted EBITDA expected to be lower than Q4 2025 due to continued seasonally weak demand and higher costs, especially in chlor-alkali.
Epoxy results projected to improve sequentially, driven by higher volumes, lower costs, and new supply agreements in Europe.
Winchester results expected to modestly improve, with higher commercial ammunition volume and pricing offsetting rising input costs.
Full-year 2026 outlook for chlor-alkali remains challenging, with global vinyls pricing under pressure and rising U.S. input costs.
Expect to realize $100–$120 million in additional annual cost savings in 2026 from Beyond250 program.
Latest events from Olin
- Key votes on directors, executive pay, new incentive plan, and auditor highlight governance and ESG focus.OLN
Proxy filing20 Mar 2026 - Annual meeting proxy materials filed; no filing fee required.OLN
Proxy filing20 Mar 2026 - Q2 profit fell year-over-year; Hurricane Beryl to reduce Q3 EBITDA by $100M.OLN
Q2 20242 Feb 2026 - Q3 net loss from hurricane and weak demand, but caustic soda prices and military sales improved.OLN
Q3 202418 Jan 2026 - 2029 targets: ~$2B EBITDA, >$250M cost savings, >50% cash return, with disciplined growth focus.OLN
Investor Day 202411 Jan 2026 - Q4 2024 EBITDA was $193.4M; AMMO, Inc. deal and PVC resin entry set for 2025.OLN
Q4 20249 Jan 2026 - Net income and EBITDA fell, but cost controls, refinancing, and military demand support outlook.OLN
Q1 202523 Dec 2025 - Director elections, executive pay, and auditor ratification headline the 2025 annual meeting.OLN
Proxy Filing1 Dec 2025 - Performance-based pay, strong governance, and ESG focus highlight this year's proxy.OLN
Proxy Filing1 Dec 2025